BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11224524)

  • 21. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells.
    Sun L; Vitolo MI; Qiao M; Anglin IE; Passaniti A
    Oncogene; 2004 Jun; 23(27):4722-34. PubMed ID: 15107836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redirection of B cell responsiveness by transforming growth factor beta receptor.
    Roes J; Choi BK; Cazac BB
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7241-6. PubMed ID: 12773615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-binding proteins mediate TGF-beta 1-induced apoptosis in bovine mammary epithelial BME-UV1 cells.
    Gajewska M; Motyl T
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):65-75. PubMed ID: 15556067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of cytokine signaling pathways of the transforming growth factor-beta (TGF-beta) family in the regulation of hematopoiesis].
    Fuchs O
    Cas Lek Cesk; 2002 Sep; 141 Suppl():18-22. PubMed ID: 12428417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta-3 is mitogenic for rat retinal progenitor cells in vitro.
    Anchan RM; Reh TA
    J Neurobiol; 1995 Oct; 28(2):133-45. PubMed ID: 8537820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic modification of human B-cell development: B-cell development is inhibited by the dominant negative helix loop helix factor Id3.
    Jaleco AC; Stegmann AP; Heemskerk MH; Couwenberg F; Bakker AQ; Weijer K; Spits H
    Blood; 1999 Oct; 94(8):2637-46. PubMed ID: 10515867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Id proteins in B lymphocyte activation: new insights from knockout mouse studies.
    Sugai M; Gonda H; Nambu Y; Yokota Y; Shimizu A
    J Mol Med (Berl); 2004 Sep; 82(9):592-9. PubMed ID: 15184986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E protein function in lymphocyte development.
    Quong MW; Romanow WJ; Murre C
    Annu Rev Immunol; 2002; 20():301-22. PubMed ID: 11861605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching.
    Chambers RC; Leoni P; Kaminski N; Laurent GJ; Heller RA
    Am J Pathol; 2003 Feb; 162(2):533-46. PubMed ID: 12547711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.
    Pan L; Sato S; Frederick JP; Sun XH; Zhuang Y
    Mol Cell Biol; 1999 Sep; 19(9):5969-80. PubMed ID: 10454544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Id3 induces growth arrest and caspase-2-dependent apoptosis in B lymphocyte progenitors.
    Kee BL
    J Immunol; 2005 Oct; 175(7):4518-27. PubMed ID: 16177095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Null mutation of the transcription factor inhibitor of DNA binding 3 (ID3) in male mice adversely impacts on fertility and reproductive outcome.
    Carroll M; Robaire B
    J Androl; 2012; 33(4):667-74. PubMed ID: 22016354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF-beta1.
    Yusa S; Ohnishi S; Onodera T; Miyazaki T
    Eur J Immunol; 1999 Apr; 29(4):1086-93. PubMed ID: 10229074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yin outwits Yang at the IgE locus.
    Maizels N
    Nat Immunol; 2003 Jan; 4(1):7-8. PubMed ID: 12496968
    [No Abstract]   [Full Text] [Related]  

  • 35. A role for an alternatively spliced Id3 isoform in vascular lesions?
    Christy BA
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):727-8. PubMed ID: 11348865
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of Transforming Growth Factor 1 in Lymphocyte Development and Death.
    Bommireddy R; Ormsby I; Yin M; Doetschman TC
    ScientificWorldJournal; 2001; 1():146. PubMed ID: 30147623
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
    Rodriguez-Rodriguez N; Clark PA; Gogoi M; Ferreira ACF; Kerscher B; Crisp A; Jolin HE; Murphy JE; Sivasubramaniam M; Pedro L; Walker JA; Heycock MWD; Shields JD; Barlow JL; McKenzie ANJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2203454119. PubMed ID: 36442116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitor of DNA binding proteins revealed as orchestrators of steady state, stress and malignant hematopoiesis.
    Singh S; Sarkar T; Jakubison B; Gadomski S; Spradlin A; Gudmundsson KO; Keller JR
    Front Immunol; 2022; 13():934624. PubMed ID: 35990659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma.
    Zhang J; Zou Y; Chen L; Xu Q; Wang Y; Xie M; Liu X; Zhao J; Wang CY
    Front Immunol; 2022; 13():902318. PubMed ID: 35757774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helix-Loop-Helix Proteins in Adaptive Immune Development.
    Aubrey M; Warburg ZJ; Murre C
    Front Immunol; 2022; 13():881656. PubMed ID: 35634342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.